iRhythm Holdings (IRTC) EBITDA Margin (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly EBITDA Margin came in at 1.13% in Q2 2026, up 889.0% year-over-year from 0.11% in Q2 2025, and up 86.03% quarter-over-quarter from 8.12% in Q1 2026.
Analysis
iRhythm Holdings (IRTC) EBITDA Margin (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported EBITDA Margin for 12 consecutive years, with 1.13% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 889.0% year-over-year to 1.13% in Q2 2026; TTM through Jun 2026 was 3.01%, a 1306.0% increase from a year earlier, with the FY2025 full-year figure at 7.68%, up 1183.0% from the prior year.
- EBITDA Margin was 1.13% for Q2 2026 at iRhythm Holdings, up from 8.12% in the prior quarter.
- Over five years, EBITDA Margin peaked at 1.09% in Q4 2025 and troughed at 52.55% in Q1 2022.
- A 5-year average of 18.93% and a median of 19.34% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin plunged 1559 bps in 2022 and surged 2972 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 18.38% in 2022, then slumped by 61 bps to 29.57% in 2023, then jumped by 92 bps to 2.48% in 2024, then soared by 144 bps to 1.09% in 2025, then sank by 204 bps to 1.13% in 2026.
- The last three EBITDA Margin figures came in at 1.13% (Q2 2026), 8.12% (Q1 2026), and 1.09% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.07 Bn | 45.97 Bn | 486.15 Mn | -10.07% |
| 2 | Labcorp Holdings | 26.22 Bn | 26.08 Bn | 1.11 Bn | 12.10% |
| 3 | Quest Diagnostics | 25.95 Bn | 25.32 Bn | 1.03 Bn | 15.08% |
| 4 | Guardant Health | 21.86 Bn | 20.80 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 11.23 Bn | 10.41 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 6.95 Bn | 6.16 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.25 Bn | 4.89 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.71 Bn | 4.16 Bn | 77.11 Mn | 5.03% |
| 9 | iRhythm Holdings | 4.00 Bn | 3.41 Bn | 163.21 Mn | -1.13% |
| 10 | Adaptive Biotechnologies | 3.90 Bn | 3.56 Bn | 51.39 Mn | -22.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.13% |
| Mar 31, 2026 | -8.12% |
| Dec 31, 2025 | 1.09% |
| Sep 30, 2025 | -4.37% |
| Jun 30, 2025 | -10.02% |
| Mar 31, 2025 | -20.52% |
| Dec 31, 2024 | -2.48% |
| Sep 30, 2024 | -34.09% |
| Jun 30, 2024 | -15.52% |
| Mar 31, 2024 | -28.91% |
| Dec 31, 2023 | -29.57% |
| Sep 30, 2023 | -22.15% |
| Jun 30, 2023 | -15.20% |
| Mar 31, 2023 | -35.45% |
| Dec 31, 2022 | -18.38% |
| Sep 30, 2022 | -20.30% |
| Jun 30, 2022 | -22.98% |
| Mar 31, 2022 | -52.55% |
| Dec 31, 2021 | -39.36% |
| Sep 30, 2021 | -27.25% |